Three of the top diabetes tech companies put forward new clinical data this week, making the case for their continuous glucose monitors and insulin pumps as they look to expand their reac | Three ...

DexCom, Inc. , the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and share more ...

Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026.

At 45, Lance Bass says he is "the healthiest I've ever been." The singer, actor and entertainer best known for his time in NSYNC, came to South by Southwest on Tuesday to talk about chronic illness ...

BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company's senior investor relations (IR) officials.

Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

In the preceding three months, 12 analysts have released ratings for DexCom (NASDAQ:DXCM), presenting a wide array of ...

The Stelo is available to anyone who wants to monitor their blood glucose, no prescription needed. But as an active adult without diabetes, are these extra data points worth $99 per month?

A manufacturing problem in millions of Abbott glucose sensors has been tied to at least seven deaths and hundreds of injuries worldwide.

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.

Macron to host G7 leaders call on Iran crisis, energy prices French President Emmanuel Macron will convene a call with leaders of the Group of ‌Seven on Wednesday to discuss the Iran crisis and rising ...